HIV & TB Care: A Tanzania–Mozambique trial (EXULTANT) tested easier TB samples for people with HIV. Broader screening using urine, stool and mucus didn’t speed up treatment starts, but urine was far easier to collect and the urine test detected the most confirmed TB cases—stool or urine can help when mucus can’t be produced. HIV Prevention in Mozambique: Maputo’s PrEP rollout is gaining momentum: uptake of long-acting injectable lenacapavir is reported as high across 27 health facilities, with the promise of just two doses per year. Public Health Access & Safety: The US renewed a travel advisory urging citizens to avoid northern Mozambique, citing weak health infrastructure, variable medicine availability, limited routine and emergency services, and possible cash-upfront requirements. Health Funding & Systems: Malawi’s health sector is still short of its Abuja Declaration target; analysis says the country missed K646 billion over five years, leaving visible gaps like broken CT scanners and delayed care. Diabetes Outlook: New EASD research projects type 1 diabetes will rise globally by 29% to 12.1 million by 2049, with the steepest relative growth expected in low-income countries, including parts of Africa. Climate & Disease Risk: Zimbabwe faces another hotter, drier season; forecasts warn of below-normal rainfall during key planting months, raising pressure on crops, water and disease risk.